Start exploring your own markets for free

🚀 Try for Free

AI Therapeutics

Light Search completed

Invite

Radar Tracking

Subspaces (4)

Drug Discovery Optimization

Biomarker Identification

Genomic Data Analysis

Drug Repurposing

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 104 results

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
GeneOmics Solutions	GeneOmics Solutions effectively leverages machine learning for diagnosis, discovers new patterns in data, and expands therapeutic options through its research initiatives.	Developer of personalized medicine sequencing data analysis solutions. GeneOmics Solutions integrates multi-omics data to enable research for the discovery of biomarkers and therapies for diseases such as cancers, rare diseases, autoimmune, and infectious diseases. The company offers custom pipeline development, automation and standardization, data analytical and statistical tools, data connectivity, and purpose-built dashboards to enable the discovery of biomarkers and therapeutic targets. GeneOmics Solutions specializes in AI and machine learning solutions for diagnosis and collaborates with research partners.	Genomic Data Analysis	Light Search	United Kingdom	2018	1 - 10		NA	Oct 14, 2024
Genome International	Genome International Corporation leverages machine learning and advanced algorithms to discover genetic patterns and enhance therapeutic options in genomic medicine.	Provider of research services intended to offer innovative bioinformatics products and custom research solutions for corporate, government and academic laboratories in biomedical and plant sciences. The company offers advanced cloud-based products and sequencing services to accelerate discovery in the field of genomic medicine by innovating cutting-edge algorithms and proprietary technologies to enable end-to-end molecular approaches for addressing the complexities of cancer and inherited disease for early diagnosis and treatment.	Genomic Data Analysis	Light Search	United States	1992	51 - 200		NA	Oct 14, 2024
Koonkie	Koonkie leverages machine learning for genomic data analysis, discovers biological patterns, and aims to expand therapeutic options through optimized product development.	Operator of bioinformatics platform intended for genomic data analysis. The company's platform offers machine learning algorithms and scalable software tools for workflows, data processing, and customizing interpretive reports to optimize product development, enabling healthcare businesses to optimize product development and improve process controls while reducing the barriers to effectively working with big data.	Genomic Data Analysis	Light Search	Canada	2016	1 - 10		Pre-Seed, March 1, 2020	Oct 14, 2024
Oxford Drug Design	InhibOx leverages advanced machine learning technologies and pattern discovery methods to expand therapeutic options, particularly in the development of novel antibiotics.	Operator of a biotechnology company intended to develop therapies to treat drug-resistant infections. The company's methods offer the application of new technologies to drive computer-aided drug discovery from target identification through preclinical and formulation studies and against cancer and other challenging diseases with high unmet medical needs seeking good patient outcomes, enabling healthcare professionals to access new antibiotics to treat drug-resistant bacterial infections.	Drug Discovery Optimization Drug Repurposing	Light Search	Oxford (United Kingdom)	2001	1 - 10	$11.26M	Convertible Note, $2.74M, May 19, 2022	Oct 14, 2024
Pumeirui Biotechnology	Pumeirui leverages machine learning and innovative algorithms to enhance drug discovery, focusing on expanding therapeutics and optimizing the development process.	Developer of algorithm tool designed for innovative drug discovery. The company develops algorithms to predict the structure of biological macromolecule complexes, committing to accelerating targeted cancer therapies by leveraging artificial intelligence technology	Drug Discovery Optimization	Light Search	Changzhou (China)	2020	11 - 50		Pre-Seed, November 29, 2021	Oct 14, 2024
Quant Biomarkers	Quant Biomarkers leverages machine learning for pattern discovery and therapeutic target identification, focusing on personalized biomarker development.	Operator of a biotechnology research firm intended to focus on the development and application of quantitative biomarkers. The company uses a combination of artificial intelligence, machine learning and advanced biological science to analyze large datasets of clinical data and identify patterns that can be used to predict health outcomes and identify potential therapeutic targets, enabling people to live longer, healthier lives by identifying and addressing potential health risks.	Biomarker Identification	Light Search	Basel (Switzerland)	2021	1 - 10		NA	Oct 14, 2024
Divergene	Divergene leverages machine learning to enhance genomic data analysis and supports the expansion of therapeutics in gene therapy.	Developer of AI-driven analytics and informatics for the cell and gene therapy and bioprocessing industries. Divergene's services integrate multimodal data, break down data silos, and create advanced machine learning models to offer actionable insights. Their platform provides a secure and accessible environment for the standardization, computation, and analysis of multimodal data, helping organizations to retain ownership of their samples and data. Divergene collaborates with CROs, CDMOs, and cell and gene therapy companies to enhance their next-generation sequencing capabilities.	Genomic Data Analysis	Light Search	United States		1 - 10		NA	Oct 14, 2024
Generative Tensorial Networks	GTN effectively utilizes machine learning and pattern discovery to innovate drug discovery, expanding therapeutics and optimizing the process.	Provider of a drug discovery platform intended to transform drug discovery through interdisciplinary innovation. The company's platform combines quantum physics and machine learning algorithms to transform the search and discovery of patient-centered drugs, enabling researchers to discover new medicines that are more effective and affordable while accelerating the development process.	Drug Discovery Optimization	Light Search	London (United Kingdom)	2017	11 - 50	$2.84M	Seed, November 1, 2018	Oct 14, 2024
Valence Labs	Valence Labs effectively leverages machine learning to discover patterns and expand therapeutics, while optimizing the drug discovery process.	Developer of artificial intelligence-based drug discovery platform designed to unlock small and noisy datasets. The company's platform uses bioinformatics and artificial intelligence to optimize the development of drugs through predictive analytics and work with the small and noisy datasets characteristic of low-throughput compound screens and late-stage lead optimization, enabling pharmaceutical companies to reduce the time, design, and optimize novel ligands against a broad range of precision medicine targets.	Drug Discovery Optimization	Light Search	Canada	2018	11 - 50	$8.50M	Seed, $8.50M, December 1, 2021	Oct 14, 2024
SOM Biotech	SOM Biotech leverages machine learning for drug discovery, identifies new patterns for therapeutic development, and actively engages in drug repurposing for orphan diseases.	Developer of drugs designed for the treatment of rare and critical diseases. The company's artificial intelligence-based drug discovery technology allows for reducing costs and time for drug development, providing a high level of success and reliable patent protection, and engages in the development of candidates, drug pipelines, and compounds to treat diseases, enabling the medical community to optimally combat acute and life-threatening diseases while maintaining safety and tolerance standards.	Drug Repurposing	Light Search	Spain	2009	11 - 50	$9.99M	Venture - Series Unknown, January 1, 2021	Oct 14, 2024